Qiang Su Selected Research

Aftercare (After-Treatment)

1/2022	Intervention of the Syndrome-Position Point Selection Method on Idiopathic Tinnitus of Phlegm-Fire Stagnation Pattern: A Randomized Controlled Study.
2/2021	Mindray BC-6900 Scattergram Analysis Combined with Peripheral Blood Smear in the Diagnosis of T. Marneffei Infection in an HIV-Positive Patient: a Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Su Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 07/2015
16	Inflammation (Inflammations) 01/2024 - 11/2013
15	Myocardial Infarction 03/2024 - 01/2009
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 12/2013
12	Acute Coronary Syndrome 09/2019 - 04/2012
8	Hypoxia (Hypoxemia) 09/2022 - 11/2017
8	ST Elevation Myocardial Infarction 06/2022 - 06/2013
6	Atherosclerosis 09/2022 - 01/2015
6	Infarction (Infarctions) 04/2022 - 04/2010
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 09/2016
5	Wounds and Injuries (Trauma) 02/2024 - 01/2007
5	Reperfusion Injury 10/2022 - 01/2021
5	No-Reflow Phenomenon 06/2022 - 01/2014
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 03/2021
3	Pain (Aches) 02/2024 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2018
3	Ischemia 10/2022 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 05/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 08/2017
3	Infections 02/2021 - 01/2007
3	Heart Failure 01/2021 - 01/2018
3	Pancreatitis 01/2018 - 01/2007
3	Unstable Angina 12/2017 - 01/2014
3	Shock 01/2009 - 01/2007
2	Carcinoma (Carcinomatosis) 05/2024 - 01/2023
2	Postoperative Pain 02/2024 - 02/2022
2	Hemolysis 02/2024 - 04/2011
2	Necrosis 11/2023 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 10/2023 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 05/2023 - 09/2022
2	Memory Disorders (Memory Loss) 04/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2022
2	Coma (Comas) 01/2023 - 01/2009
2	Body Weight (Weight, Body) 12/2022 - 01/2018
2	Melanoma (Melanoma, Malignant) 08/2022 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2019
2	Chemical and Drug Induced Liver Injury 12/2021 - 01/2021
2	Diarrhea 02/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2012
2	Stroke (Strokes) 01/2019 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2018 - 10/2018

Drug/Important Bio-Agent (IBA)

10	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2018
10	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2014
8	Long Noncoding RNAIBA 03/2023 - 01/2019
7	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2017
6	Hematoxylin (Haematoxylon)IBA 04/2022 - 04/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 01/2020
5	Eosine Yellowish-(YS) (Eosin)IBA 04/2022 - 04/2010
5	omega-Chloroacetophenone (Mace)IBA 01/2019 - 01/2014
4	InterleukinsIBA 09/2022 - 07/2015
4	Messenger RNA (mRNA)IBA 08/2022 - 01/2014
4	NivolumabIBA 01/2019 - 01/2018
4	picric acid (picrate)IBA 10/2018 - 04/2010
4	basic fuchsinIBA 10/2018 - 04/2010
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2022
3	Peptides (Polypeptides)IBA 10/2022 - 01/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 10/2018
3	Programmed Cell Death 1 ReceptorIBA 08/2022 - 01/2019
3	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2015
3	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2013
3	EnzymesIBA 01/2021 - 11/2017
3	Taurine FDA Link 01/2021 - 01/2019
3	Atorvastatin (Lipitor)FDA Link 01/2019 - 12/2013
3	pembrolizumabIBA 01/2019 - 01/2018
3	oxidized low density lipoproteinIBA 11/2018 - 01/2015
3	Nicorandil (SG 75)IBA 10/2018 - 11/2017
3	Trimetazidine (Vastarel)IBA 12/2017 - 03/2017
3	Verapamil (Calan)FDA LinkGeneric 05/2015 - 06/2013
2	LuciferasesIBA 05/2024 - 01/2019
2	Therapeutic UsesIBA 04/2024 - 09/2022
2	LigandsIBA 03/2024 - 08/2022
2	Cyclophilins (Cyclophilin)IBA 03/2024 - 03/2021
2	trichostatin A (A 300)IBA 01/2024 - 01/2021
2	LipopolysaccharidesIBA 01/2023 - 10/2018
2	CateninsIBA 01/2023 - 01/2021
2	CalciumIBA 01/2023 - 10/2013
2	Retinaldehyde (Retinal)IBA 12/2022 - 10/2022
2	LipidsIBA 09/2022 - 11/2017
2	Apoptosis Regulatory ProteinsIBA 08/2022 - 12/2021
2	Sincalide FDA Link 04/2022 - 01/2021
2	HydrogelsIBA 01/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 01/2021
2	CurcuminIBA 01/2022 - 01/2021
2	Circular RNAIBA 12/2021 - 01/2020
2	Cytochrome P-450 CYP2C19IBA 12/2021 - 09/2019
2	Angiogenesis InhibitorsIBA 04/2020 - 01/2018
2	apatinibIBA 04/2020 - 01/2018
2	Clopidogrel (Plavix)FDA Link 09/2019 - 01/2018
2	IpilimumabIBA 01/2019 - 01/2018
2	tetramethylpyrazineIBA 01/2019 - 11/2017
2	NF-kappa B (NF-kB)IBA 10/2018 - 09/2018

Therapy/Procedure

22	Percutaneous Coronary Intervention 10/2023 - 01/2013
18	Therapeutics 05/2024 - 01/2014
10	Drug Therapy (Chemotherapy) 04/2024 - 01/2018
4	Immunotherapy 05/2023 - 09/2022
2	Prostheses and Implants (Prosthesis) 02/2024 - 10/2021
2	Knee Replacement Arthroplasty (Total Knee Replacement) 02/2024 - 02/2022
2	Aftercare (After-Treatment) 01/2022 - 02/2021